Disorders of cholesterol biosynthesis

Archives of Disease in Childhood

Volumn 78, Issue 2, 1998, Pages 185-189

  Clayton, Peter T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 4 [2 [1 (4 CHLOROCINNAMYL) 4 PIPERAZINYL]ETHYL]BENZOIC ACID; 7 DEHYDROCHOLESTEROL; CHENODEOXYCHOLIC ACID; CHOLESTEROL; ENZYME INHIBITOR; LANOSTEROL; PYRIDINE DERIVATIVE; URSODEOXYCHOLIC ACID;

ANIMAL MODEL; CELL MEMBRANE; CHILD; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DIET SUPPLEMENTATION; ENZYME INHIBITION; FETUS; HOLOPROSENCEPHALY; HUMAN; INFANT; MULTIPLE MALFORMATION SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMITH LEMLI OPITZ SYNDROME;

EID: 0031895371     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.2.185     Document Type: Review

References (37)

1. Connolly T, Carruthers A, Melchior D. Effect of bilayer cholesterol content on reconstituted human erythrocyte sugar transporter activity. J Biol Chem 1985;260:2617-20.
2. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 1996;383:407-13.
3. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996;274:255-9.
4. Martin G. Pass the butter... Science 1996;274:203-4.
5. Acosta PB. RSH/SLO (Smith-Lemli-Opitz) syndrome: designing a high cholesterol diet for the SLO syndrome. Am J Med Genet 1994;50:358-63.
6. Lin D, Pitkin R, Connor W. Placental transfer of cholesterol into the human fetus. Am J Obstet Gynecol 1977;128:735-9.
7. Roux F, Mokni R, Hughes C, et al. Lipid synthesis by rat brain microvessel endothelial cells in tissue culture. J Neuropathol Exp Neurol 1989;48:437-47.
8. Shah S, Johnson R. Effect of serum lipoproteins on growth and sterol synthesis in cultured rat brain glial cells. J Neurochem 1988;50:1529-36.
9. Biardi L, Krisans S. Compartmentalisation of cholesterol biosynthesis. Conversion of mevalonate to farnesyl diphosphate occurs in the peroxisomes. J Biol Chem 1996;271: 1784-8.
10. Hoffmann G, Gibson KM, Brandt IK, et al. Mevalonic aciduria - an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med 1986;314:1610-4.
11. Berger R, Smit GP, Schierbeek H, et al. Mevalonic aciduria: an inborn error of cholesterol biosynthesis? Clin Chim Acta 1985;152:219-22.
12. Hoffmann GF, Charpentier C, Mayatepek E, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 1993;91:915-21.
13. Gibson KM, Hoffmann GF, Sweetman L, et al. Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduria. J Inherit Metab Dis 1997;20:391-4.
14. Batta AK, Tint GS, Shefer S, et al. Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome. J Lipid Res 1995; 36:705-13.
15. Batta AK, Salen G, Tint GS, et al. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome. J Lipid Res 1995;36:2413-8.
16. Tint GS, Irons M, Elias ER, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994;330:107-13.
17. Shefer S, Salen G, Batta AK, et al. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest 1995;96:1779-85.
18. Honda A, Tint GS, Salen G, et al. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J Lipid Res 1995;36:1595-601.
19. Lin AE, Ardinger HH, Ardinger RH, Jr, et al. Cardiovascular malformations in Smith-Lemli-Opitz syndrome. Am J Med Genet 1997;68:270-8.
20. Cunniff C, Kratz LE, Moser A, et al. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 1997;68:263-9.
21. McGaughran JM, Clayton PT, Mills KA, et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;56:269-71.
22. Mills K, Mandel H, Montemagno R, et al. First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatr Res 1996; 39:816-9.
23. Hyett JA, Clayton PT, Moscoso G, et al. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;58: 374-6.
24. Kelley R. A new face for an old syndrome [editorial]. Am J Med Genet 1997;65:251-6.
25. Alley TL, Scherer SW, Huizenga JJ, et al. Physical mapping of the chromosome 7 breakpoint region in an SLOS patient with t(7;20) (q32.1;q13.2). Am J Med Genet 1997;68:279-81.
26. Clayton P, Mills K, Keeling J, et al. Desmosterolosis: a new inborn error of cholesterol biosynthesis [letter]. Lancet 1996;348:404.
27. FitzPatrick D, Keeling J, Evans M, et al. The clinical phenotype of desmosterolosis. Am J Med Genet (in press).
28. Barbu V, Roux C, Lambert D, et al. Cholesterol prevents the teratogenic action of AY 9944: importance of the timing of cholesterol supplementation to rats. J Nutr 1988;118:774-9.
29. Xu G, Salen G, Shefer S, et al. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766. Gastroenterology 1995;109: 1301-7.
30. Dehart DB, Lanoue L, Tint GS, et al. Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. Am J Med Genet 1997;68:328-37.
31. Irons M, Elias ER, Tint GS, et al. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am J Med Genet 1994;50:347-52.
32. Ullrich K, Koch HG, Meschede D, et al. Smith-Lemli-Opitz syndrome: treatment with cholesterol and bile acids [letter]. Neuropediatrics 1996;27:111-2.
33. Nwokoro NA, Mulvihill JJ. Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. Am J Med Genet 1997;68:315-21.
34. Irons M, Elias ER, Abuelo D, et al. Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet 1997;68:311-4.
35. Elias ER, Irons MB, Hurley AD, et al. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet 1997;68: 305-10.
36. Jira P, Wevers R, dejong J, et al. New treatment strategy for Smith-Lemli-Opitz syndrome [letter]. Lancet 1997;349: 1222.
37. Ness GC, Lopez D, Borrego O, et al. Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. Am J Med Genet 1997; 68:294-9.